D-0880-2022 Class III Terminated
FDA drug recall D-0880-2022 was initiated by American Health Packaging on May 3, 2022 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time. The recall status is terminated (terminated Sep 28, 2023). Affected quantity: 1603 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- May 25, 2022
- Initiation Date
- May 3, 2022
- Termination Date
- Sep 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1603 cartons
Product description
Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10 cards per carton, Unit Dose NDC 68084-446-11, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 68084-446-01
Reason for recall
Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
Distribution pattern
Nationwide USA
Code information
Lot # 1003829, Exp date 1/31/23
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0880-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026